AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

BioLineRx Ltd.

Regulatory Filings Apr 5, 2012

6692_rns_2012-04-05_cd5ac40b-f768-40a4-9c9e-2dba4bafa6de.htm

Regulatory Filings

Open in Viewer

Opens in native device viewer

_________ false

C007������� �� ��� ��"�2PublicBIOLINE RX LTD9253Corporation no: 513398750Stock Exchange/Market: ������� �� ���2271428����� 19 , ������� 91450 , ,Tel: 02-5489100 , 02-5489116 Fax: 02-5489101E.mail address: [email protected] of transmission: 05/04/2012              Time of broadcast: 13:55 13:38:56

Reference: 2012-02-096429

Israel Securities Authority Tel Aviv Stock Exchange
www.isa.gov.il www.tase.co.il

Annual General Meeting / Special MeetingRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000Only for corporation incorporated in Israel

On 15/05/2012 at 11:00 the corporation will hold it's annual general meetingat 19 Hartum Street, Har Hotzvim, JerusalemNumber of the security that entitles its holder to vote at the meeting: 1101518The Number - as given by the Tel Aviv Stock Exchange

According to section 182 _________ of the Companies law, 5759-1999, only shareholders of record at the close of business 10/04/2012 will be entitled to notice of, and to vote at, the Meeting.

Attached hereto is the report Notice_AGM2012_isa.pdf

Attached hereto is the proxy statement 6K_AGM2012_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 14/03/2012
- - -
Name of the Signatory: : Kotler Norman Harold , Position of Signatory in the reporting corporation: General Counsel , Name of Employer Company: .
Hartum Telephone: 02-5489100 , Facsimile: 02-5489101 , E-mail: [email protected] 2

Talk to a Data Expert

Have a question? We'll get back to you promptly.